Advertisement

Central European Journal of Medicine

, Volume 7, Issue 3, pp 310–316 | Cite as

Coffee consumption and risk of stroke: a meta-analysis of cohort studies

  • Rui Zhang
  • Yan Wang
  • Bo Song
  • Hans Stødkilde Jørgensen
  • Yuming XuEmail author
Research Article

Abstract

Aims

Several studies have been done to investigate the correlation between coffee consumption and risk of stroke. The results are inconsistent. This meta-analysis is to evaluate the pooled effect of coffee consumption on risk of stroke.

Methods

We searched PubMed and Embase for all cohort studies on stroke and coffee consumption in humans with original data. Data from 13 studies involving 12414 stroke cases among 492760 individuals were pooled. The outcome considered was the occurrence of any type of stroke. Fixed effect model was used for the analysis of pooled relative risk. Heterogeneity was tested. If any existed, randomized effect model was used.

Results

Comparing with non coffee drinking, all coffee consumption could reduce total stroke by 11% (95%CI: 0.81, 0.97). In women, coffee consumption could reduce stroke risk by 17% (95%CI: 0.79, 0.87). Although there is no statistical difference in men, coffee consumption showed the tendency of decreasing stroke risk. Light, moderate and heavy coffee consumption could reduce the all type stroke risk by 10% (95%CI: 0.85, 0.96), 14% (95%CI: 0.76, 0.97), and 17% (95%CI: 0.78, 0.89) respectively.

Conclusions

This meta-analysis is strongly supportive of the hypothesis that coffee consumption at different level, reduces the risk of stroke.

Keywords

Stroke Risk Coffee Caffeine Meta analysis Cohort studies 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Muntner P., Garrett E., Klag MJ., Coresh J., Trends in stroke prevalence between 1973 and 1991 in the US population 25 to 74 years of age, Stroke., 2002, 33, 1209–1213PubMedCrossRefGoogle Scholar
  2. [2]
    Mandel HG., Update on caffeine consumption, disposition and action, Food Chem Toxicol., 2002, 40, 1231–1234PubMedCrossRefGoogle Scholar
  3. [3]
    Yukawa GS., Mune M., Otani H., Tone Y., Liang XM., Iwahashi H., et al., Effects of coffee consumption on oxidative susceptibility of low-density lipoproteins and serum lipid levels in humans, Biochemistry (Mosc)., 2004, 69, 70–74CrossRefGoogle Scholar
  4. [4]
    Lopez-Garcia E., van Dam RM., Qi L., Hu FB., Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women, Am J Clin Nutr., 2006, 84, 888–893PubMedGoogle Scholar
  5. [5]
    van Dam RM., Hu FB., Coffee consumption and risk of type 2 diabetes: a systematic review, JAMA., 2005, 294, 97–104PubMedCrossRefGoogle Scholar
  6. [6]
    Sofi F., Conti AA., Gori AM., Eliana Luisi ML., Casini A., Abbate R., et al., Coffee consumption and risk of coronary heart disease: a meta-analysis, Nutr Metab Cardiovasc Dis., 2007, 17, 209–223PubMedCrossRefGoogle Scholar
  7. [7]
    Wu JN., Ho SC., Zhou C., Ling WH., Chen WQ., Wang CL., et al., Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies, Int J Cardiol., 2009, 137, 216–225PubMedCrossRefGoogle Scholar
  8. [8]
    Stang A., Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses, Eur J Epidemiol., 2010, 25, 603–605PubMedCrossRefGoogle Scholar
  9. [9]
    Hakim AA., Ross GW., Curb JD., Rodriguez BL., Burchfiel CM., Sharp DS., et al., Coffee consumption in hypertensive men in older middle-age and the risk of stroke: the Honolulu Heart Program, J Clin Epidemiol., 1998, 51, 487–494PubMedCrossRefGoogle Scholar
  10. [10]
    Lopez-Garcia E., Rodriguez-Artalejo F., Rexrode KM., Logroscino G., Hu FB., van Dam RM., Coffee consumption and risk of stroke in women, Circulation., 2009, 119, 1116–1123PubMedCrossRefGoogle Scholar
  11. [11]
    Zhang WL., Lopez-Garcia E., Li TY., Hu FB., van Dam RM., Coffee consumption and risk of cardiovascular events and all-cause mortality among women with type 2 diabetes, Diabetologia., 2009, 52, 810–817PubMedCrossRefGoogle Scholar
  12. [12]
    Grobbee DE., Rimm EB., Giovannucci E., Colditz G., Stampfer M., Willett W., Coffee, caffeine, and cardiovascular disease in men, N Engl J Med., 1990, 323, 1026–1032PubMedCrossRefGoogle Scholar
  13. [13]
    Larsson SC., Mannisto S., Virtanen MJ., Kontto J., Albanes D., Virtamo J., Coffee and tea consumption and risk of stroke subtypes in male smokers., Stroke., 2008, 39, 1681–1687PubMedCrossRefGoogle Scholar
  14. [14]
    Bidel S., Hu G., Qiao Q., Jousilahti P., Antikainen R., Tuomilehto J., Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes, Diabetologia., 2006, 49, 2618–2626PubMedCrossRefGoogle Scholar
  15. [15]
    Larsson SC., Virtamo J., Wolk A., Coffee consumption and risk of stroke in women, Stroke., 2011, 42, 908–912PubMedCrossRefGoogle Scholar
  16. [16]
    Mukamal KJ., Hallqvist J., Hammar N., Ljung R., Gemes K., Ahlbom A., et al., Coffee consumption and mortality after acute myocardial infarction: the Stockholm Heart Epidemiology Program, Am Heart J., 2009, 157, 495–501PubMedCrossRefGoogle Scholar
  17. [17]
    de Koning Gans JM., Uiterwaal CS., van der Schouw YT., Boer JM., Grobbee DE., Verschuren WM., et al., Tea and coffee consumption and cardiovascular morbidity and mortality, Arterioscler Thromb Vasc Biol., 2010, 30, 1665–1671PubMedCrossRefGoogle Scholar
  18. [18]
    Leurs LJ., Schouten LJ., Goldbohm RA., van den Brandt PA., Total fluid and specific beverage intake and mortality due to IHD and stroke in the Netherlands Cohort Study, Br J Nutr., 2010, 104, 1212–1221PubMedCrossRefGoogle Scholar
  19. [19]
    Silletta MG., Marfisi R., Levantesi G., Boccanelli A., Chieffo C., Franzosi M., et al., Coffee consumption and risk of cardiovascular events after acute myocardial infarction: results from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico) — Prevenzione trial, Circulation., 2007, 116, 2944–2951PubMedCrossRefGoogle Scholar
  20. [20]
    Sugiyama K., Kuriyama S., Akhter M., Kakizaki M., Nakaya N., Ohmori-Matsuda K., et al., Coffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women, J Nutr., 2010, 140, 1007–1013PubMedCrossRefGoogle Scholar
  21. [21]
    Mineharu Y., Koizumi A., Wada Y., Iso H., Watanabe Y., Date C., et al., Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women, J Epidemiol Community Health., 2011, 65, 230–240PubMedCrossRefGoogle Scholar
  22. [22]
    Greenberg JA., Dunbar CC., Schnoll R., Kokolis R., Kokolis S., Kassotis J., Caffeinated beverage intake and the risk of heart disease mortality in the elderly: a prospective analysis, Am J Clin Nutr., 2007, 85, 392–398PubMedGoogle Scholar
  23. [23]
    Gomez-Ruiz JA., Leake DS., Ames JM., In vitro antioxidant activity of coffee compounds and their metabolites, J Agric Food Chem., 2007, 55, 6962–6969PubMedCrossRefGoogle Scholar
  24. [24]
    Arnlov J., Vessby B., Riserus U., Coffee consumption and insulin sensitivity, JAMA., 2004, 291, 1199–1201PubMedCrossRefGoogle Scholar

Copyright information

© © Versita Warsaw and Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Rui Zhang
    • 1
    • 2
  • Yan Wang
    • 3
  • Bo Song
    • 1
  • Hans Stødkilde Jørgensen
    • 2
  • Yuming Xu
    • 1
    Email author
  1. 1.Department of NeurologyThe first affiliated hospital of Zhengzhou UniversityZhengzhouChina
  2. 2.The MR Research CentreAarhus University HospitalAarhus NDenmark
  3. 3.Department of UrologyThe first affiliated hospital of Zhengzhou UniversityZhengzhouChina

Personalised recommendations